Regional Health Properties CEO Acquires 113,000 Shares Through Options & Grant

Accepted by SEC EDGAR 06/23/2025 - 06:37 AM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Brent Morrison, CEO, President and Director of Regional Health Properties (NYSE: RHE), reported significant insider transactions on June 20, 2025:

Exercised two stock options: - 24,000 shares at $3.32 per share - 24,000 shares at $2.03 per share
Received a grant of 65,000 restricted shares as 2023 bonus compensation, vesting in equal installments on June 20, 2026 and 2027
Following these transactions, Morrison now beneficially owns: - 198,047 shares directly - 2,272 shares indirectly through an IRA

The exercised options included a fully vested grant from January 2023 and another grant from January 2024 that completed vesting in January 2025. This significant increase in direct ownership demonstrates long-term commitment from the company's chief executive.

Positive

CEO Brent Morrison received a significant equity grant of 65,000 restricted shares as 2023 bonus, demonstrating long-term alignment with shareholders
CEO exercised options for 48,000 shares at prices of $3.32 and $2.03, increasing direct ownership to 198,047 shares, showing confidence in company

Negative

None.

Insider Trade Summary

48,000 shares exercised/converted

Exercise 5 txns

Insider Morrison Brent

Role CEO and President

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (right to buy)	24,000	$0.00	$0.00
Exercise	Employee Stock Option (right to buy)	24,000	$0.00	$0.00
Exercise	Common Stock	24,000	$3.32	$80K
Exercise	Common Stock	24,000	$2.03	$49K
Grant/Award	Common Stock	65,000	$0.00	$0.00
Holding	Common Stock	--	--	--

Holdings After Transaction: Employee Stock Option (right to buy) — 0 contracts (Direct); Common Stock — 198,047 shares (Direct); Common Stock — 2,272 shares (Indirect, By IRA)

Footnotes (3)

F1. Grant of restricted stock that was awarded to the reporting person for his 2023 bonus. The restricted stock will vest in two equal installments on June 20, 2026 and June 20, 2027.
F2. The stock option vested in its entirety upon grant.
F3. 11,250 shares underlying this stock option vested on the grant date of January 1, 2024. The remaining 12,750 shares underlying the stock option vested on January 1, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RHE shares did CEO Brent Morrison acquire on June 20, 2025?

On June 20, 2025, CEO Brent Morrison acquired a total of 113,000 shares: 24,000 shares through exercising options at $3.32, another 24,000 shares through options at $2.03, and 65,000 shares as a restricted stock grant for his 2023 bonus.

What is the vesting schedule for RHE CEO's new restricted stock grant?

The 65,000 shares of restricted stock granted to CEO Brent Morrison will vest in two equal installments: 32,500 shares on June 20, 2026, and 32,500 shares on June 20, 2027.

How many RHE shares does Brent Morrison own after the June 20, 2025 transactions?

After the transactions, Brent Morrison owns 200,319 shares total, consisting of 198,047 shares held directly and 2,272 shares held indirectly through an IRA.

What was the exercise price of RHE stock options exercised by the CEO?

CEO Brent Morrison exercised two sets of stock options: 24,000 shares at an exercise price of $3.32 per share and another 24,000 shares at $2.03 per share.

What positions does Brent Morrison hold at Regional Health Properties (RHE)?

Brent Morrison serves as both the CEO and President of Regional Health Properties (RHE), and he is also a member of the company's Board of Directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morrison Brent

(Last)

(First)

(Middle)

C/O REGIONAL HEALTH PROPERTIES, INC

1050 CROWN POINTE PARKWAY SUITE 720

(Street)

ATLANTA

30338

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
REGIONAL HEALTH PROPERTIES, INC [ RHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/20/2025		M		24,000	A	$3.32	109,047	D
Common Stock	06/20/2025		M		24,000	A	$2.03	133,047	D
Common Stock	06/20/2025		A⁽¹⁾		65,000	A	$0	198,047	D
Common Stock								2,272	I	By IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (right to buy)	$3.32	06/20/2025		M			24,000	01/01/2023⁽²⁾	01/01/2033	Common Stock	24,000	$0	0	D
Employee Stock Option (right to buy)	$2.03	06/20/2025		M			24,000	⁽³⁾	01/01/2034	Common Stock	24,000	$0	0	D

Explanation of Responses:

1. Grant of restricted stock that was awarded to the reporting person for his 2023 bonus. The restricted stock will vest in two equal installments on June 20, 2026 and June 20, 2027.

2. The stock option vested in its entirety upon grant.

3. 11,250 shares underlying this stock option vested on the grant date of January 1, 2024. The remaining 12,750 shares underlying the stock option vested on January 1, 2025.

	/s/ Brent Morrison	06/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR